Ventus
is a Canada-based biopharmaceutical company that develops and commercializes small-molecule drugs to treat diseases including autoimmune and inflammatory... Read moreVentus
is a Canada-based biopharmaceutical company that develops and commercializes small-molecule drugs to treat diseases including autoimmune and inflammatory... Read more
President & CEO
Marcelo Bigal
News
Mar 10, 2025
Business Wire
Press Release: Ventus : Ventus Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating VENT-02, an Oral, Brain-Penetrant NLRP3 Inhibitor, in Parkinson's Disease
Mar 06, 2025
Business Wire
Press Release: Ventus : Ventus Therapeutics Announces Nature Reviews Immunology Publication Demonstrating the Promise of Caspase-4/5 as Therapeutic Targets
Oct 31, 2024
Business Wire
Press Release: Ventus : Ventus Therapeutics Announces Successful Completion of Phase 1 Clinical Trial of VENT-03, a First-in-Class, Orally Administered cGAS Inhibitor
Jul 16, 2024
Citybizlist
Ventus: Ventus Therapeutics Opens New Laboratory and Office Facility in Montreal, Canada
May 07, 2024
Pharmabiz
Ventus: Ventus Therapeutics' partner Novo Nordisk doses first participant in phase 1 clinical study for NNC60220001, an oral NLRP3 inhibitor
Apr 17, 2024
Business Wire
Press Release: Ventus : Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Apr 08, 2024
Yahoo
Ventus: Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Jan 03, 2024
Business Wire
Press Release: Ventus : Ventus Therapeutics Initiates Clinical Testing of VENT-03, a First-in-Class, Orally Administered cGAS Inhibitor
Jan 02, 2024
Yahoo
Ventus: Ventus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Nov 09, 2023
Yahoo
Ventus: Ventus Therapeutics to Present at the Stifel 2023 Healthcare Conference
Ventus Competitors
1
2
3
4
5
6
7
8
9
10